Ravi Penmetsa

All Premium

China’s Fosun to acquire majority stake in KKR-backed Gland Pharma for $1.26 bn

China’s Fosun to acquire majority stake in KKR-backed Gland Pharma for $1.26 bn

3 Years ago

China's Shanghai Fosun Pharmaceuticals (Group) Co. Ltd will acquire a majority ...